β-Lactam/β-Lactamase Inhibitor Combinations Non-Susceptible ESBL-Producing Enterobacteriaceae Bloodstream Infections: An Underestimated Clinical Entity

β-Lactam/β-Lactamase Inhibitor Combinations Non-Susceptible ESBL-Producing Enterobacteriaceae Bloodstream Infections: An Underestimated Clinical Entity

Yan Zhang,1,* Shuangling Ni,2,* Hangbin Hu,3,* Sheng Zhang,4 Haiting Feng,4 Lingmei Ni,4 Hongchao Chen,5 Qing Yang,5 Meihong Yu,1 Tingting Qu1,4 1State Key Laboratory for Diagnosis and Treatment of Infectious Disease, National Clinical Research Center for Infectio...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhang Y, Ni S, Hu H, Zhang S, Feng H, Ni L, Chen H, Yang Q, Yu M, Qu T
Format: Article
Language:English
Published: Dove Medical Press 2025-05-01
Series:Infection and Drug Resistance
Subjects:
extended spectrum β-lactamase
β-lactam/β-lactamase inhibitors combinations
bloodstream infections
Enterobacteriaceae
Online Access:https://www.dovepress.com/-lactam-lactamase-inhibitor-combinations-non-susceptible-esbl-producin-peer-reviewed-fulltext-article-IDR
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://www.dovepress.com/-lactam-lactamase-inhibitor-combinations-non-susceptible-esbl-producin-peer-reviewed-fulltext-article-IDR

Similar Items